β-Arrestin1 and Signal-transducing Adaptor Molecule 1 (STAM1) Cooperate to Promote Focal Adhesion Kinase Autophosphorylation and Chemotaxis Via the Chemokine Receptor CXCR4
Overview
Authors
Affiliations
The chemokine receptor CXCR4 and its chemokine ligand CXCL12 mediate directed cell migration during organogenesis, immune responses, and metastatic disease. However, the mechanisms governing CXCL12/CXCR4-dependent chemotaxis remain poorly understood. Here, we show that the β-arrestin1·signal-transducing adaptor molecule 1 (STAM1) complex, initially identified to govern lysosomal trafficking of CXCR4, also mediates CXCR4-dependent chemotaxis. Expression of minigene fragments from β-arrestin1 or STAM1, known to disrupt the β-arrestin1·STAM1 complex, and RNAi against β-arrestin1 or STAM1, attenuates CXCL12-induced chemotaxis. The β-arrestin1·STAM1 complex is necessary for promoting autophosphorylation of focal adhesion kinase (FAK). FAK is necessary for CXCL12-induced chemotaxis and associates with and localizes with β-arrestin1 and STAM1 in a CXCL12-dependent manner. Our data reveal previously unknown roles in CXCR4-dependent chemotaxis for β-arrestin1 and STAM1, which we propose act in concert to regulate FAK signaling. The β-arrestin1·STAM1 complex is a promising target for blocking CXCR4-promoted FAK autophosphorylation and chemotaxis.
SNX9 family mediates βarrestin-independent GPCR endocytosis.
Robleto V, Zhuo Y, Crecelius J, Benzow S, Marchese A Commun Biol. 2024; 7(1):1455.
PMID: 39511325 PMC: 11544122. DOI: 10.1038/s42003-024-07157-7.
Receptor Determinants for β-Arrestin Functional Specificity at Chemokine Receptor 5.
Crecelius J, Manz A, Benzow S, Marchese A Mol Pharmacol. 2024; 106(6):287-297.
PMID: 39472027 PMC: 11585254. DOI: 10.1124/molpharm.124.000942.
β-arrestin1 is an E3 ubiquitin ligase adaptor for substrate linear polyubiquitination.
McElrath C, Benzow S, Zhuo Y, Marchese A J Biol Chem. 2023; 299(12):105474.
PMID: 37981209 PMC: 10755771. DOI: 10.1016/j.jbc.2023.105474.
-Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives.
Wess J, Oteng A, Rivera-Gonzalez O, Gurevich E, Gurevich V Pharmacol Rev. 2023; 75(5):854-884.
PMID: 37028945 PMC: 10441628. DOI: 10.1124/pharmrev.121.000302.
Zhuo Y, Robleto V, Marchese A Int J Mol Sci. 2023; 24(4).
PMID: 36834700 PMC: 9967311. DOI: 10.3390/ijms24043285.